Abstract
Bacterial urinary tract infections (UTIs) are one of the most common reasons for children to be admitted to hospital. Bacteria infect and invade the bladder (the lower urinary tract) and if the infection disseminates to the upper urinary tract, significant inflammation in the kidneys may arise. Inflammation is a double-edged sword: it is needed to clear bacteria, but if excessive, kidney tissue is injured. During injury, nephrons are destroyed and replaced with deposition of extracellular matrix and a renal scar. In this review, we explore the pathogenesis of UTIs and discuss the risk factors that result in dissemination of bladder infection to the kidneys. Three major risk factors predispose to kidney infections: the presence of vesicoureteric reflux, the presence of bladder and bowel dysfunction, and defects in the ability of the host immune response to clear bacteria. In this review, we will discuss these factors, their relationship to renal scarring, and potential treatments that might be beneficial to prevent renal scar formation in children.
Similar content being viewed by others
References
CORR (2010) Annual report. http://secure.cihi.ca/cihiweb/products/2011_CORR_Annual_Report_final_e.pdf. Accessed 23 Nov. 2018
NAPRTCS (2014) Annual transplant report. https://web.emmes.com/study/ped/annlrept/annualrept2014.pdf. Accessed 23 Nov. 2018
Ardissino G, Dacco V, Testa S, Bonaudo R, Claris-Appiani A, Taioli E, Marra G, Edefonti A, Sereni F (2003) Epidemiology of chronic renal failure in children: data from the ItalKid project. Pediatrics 111:e382–e387
Keren R, Shaikh N, Pohl H, Gravens-Mueller L, Ivanova A, Zaoutis L, Patel M, de Berardinis R, Parker A, Bhatnagar S, Haralam MA, Pope M, Kearney D, Sprague B, Barrera R, Viteri B, Egigueron M, Shah N, Hoberman A (2015) Risk factors for recurrent urinary tract infection and renal scarring. Pediatrics 136:e13–e21. https://doi.org/10.1542/peds.2015-0409
Hoberman A, RIVUR Trial Investigators, Greenfield SP, Mattoo TK et al (2014) Antimicrobial prophylaxis for children with vesicoureteral reflux. N Engl J Med 370:2367–2376. https://doi.org/10.1056/NEJMoa1401811
Mattoo TK, Chesney RW, Greenfield SP, Hoberman A, Keren R, Mathews R, Gravens-Mueller L, Ivanova A, Carpenter MA, Moxey-Mims M, Majd M, Ziessman HA, RIVUR Trial Investigators (2016) Renal scarring in the randomized intervention for children with vesicoureteral reflux (RIVUR) Trial. Clin J Am Soc Nephrol 11:54–61. https://doi.org/10.2215/CJN.05210515
Nguyen HT, Bauer SB, Peters CA, Connolly LP, Gobet R, Borer JG, Barnewolt CE, Ephraim PL, Treves ST, Retik AB (2000) 99m Technetium dimercapto-succinic acid renal scintigraphy abnormalities in infants with sterile high grade vesicoureteral reflux. J Urol 164:1674–1678 discussion 1678-1679
Silva JM, Oliveira EA, Diniz JS, Cardoso LS, Vergara RM, Vasconcelos MA, Santo DE (2006) Gender and vesico-ureteral reflux: a multivariate analysis. Pediatr Nephrol 21:510–516. https://doi.org/10.1007/s00467-006-0011-z
Gilliver SC, Ashworth JJ, Mills SJ, Hardman MJ, Ashcroft GS (2006) Androgens modulate the inflammatory response during acute wound healing. J Cell Sci 119:722–732. https://doi.org/10.1242/jcs.02786
Olson PD, Hruska KA, Hunstad DA (2016) Androgens enhance male urinary tract infection severity in a new model. J Am Soc Nephrol 27:1625–1634. https://doi.org/10.1681/asn.2015030327
Lee G, Romih R, Zupančič D (2014) Cystitis: from urothelial cell biology to clinical applications. Biomed Res Int 2014:10. https://doi.org/10.1155/2014/473536
Deo SS, Vaidya AK (2004) Elevated levels of secretory immunoglobulin A (sIgA) in urinary tract infections. Indian J Pediatr 71:37–40
Valore EV, Park CH, Quayle AJ, Wiles KR, McCray PBJ, Ganz T (1998) Human beta-defensin-1: an antimicrobial peptide of urogenital tissues. J Clin Invest 101:1633–1642. https://doi.org/10.1172/JCI1861
Chromek M, Slamová Z, Bergman P, Kovács L, Lu P, Ehrén I, Hökfelt T, Gudmundsson GH, Gallo RL, Agerberth B, Brauner A (2006) The antimicrobial peptide cathelicidin protects the urinary tract against invasive bacterial infection. Nat Med 12:636. https://doi.org/10.1038/nm1407https://www.nature.com/articles/nm1407#supplementary-information
Nielsen KL, Dynesen P, Larsen P, Jakobsen L, Andersen PS, Frimodt-Møller N (2014) Role of urinary cathelicidin LL-37 and human β-defensin 1 in uncomplicated Escherichia coli urinary tract infections. Infect Immun 82:1572–1578. https://doi.org/10.1128/iai.01393-13
Sivick KE, Schaller MA, Smith SN, Mobley HLT (2010) The innate immune response to Uropathogenic Escherichia coli involves IL-17A in a murine model of urinary tract infection. J Immunol 184:2065. https://doi.org/10.4049/jimmunol.0902386
Samuelsson P, Hang L, Wullt B, Irjala H, Svanborg C (2004) Toll-like receptor 4 expression and cytokine responses in the human urinary tract mucosa. Infect Immun 72:3179–3186. https://doi.org/10.1128/IAI.72.6.3179-3186.2004
Song J, Abraham SN (2008) TLR mediated immune responses in the urinary tract. Curr Opin Microbiol 11:66–73. https://doi.org/10.1016/j.mib.2007.12.001
Zhang D, Zhang G, Hayden MS, Greenblatt MB, Bussey C, Flavell RA, Ghosh S (2004) A toll-like receptor that prevents infection by uropathogenic bacteria. Science 303:1522–1526. https://doi.org/10.1126/science.1094351
Godaly G, Bergsten G, Hang L, Fischer H, Frendéus B, Lundstedt A-C, Samuelsson M, Samuelsson P, Svanborg C (2001) Neutrophil recruitment, chemokine receptors, and resistance to mucosal infection. J Leukoc Biol 69:899–906. https://doi.org/10.1189/jlb.69.6.899
Song J, Bishop BL, Li G, Duncan MJ, Abraham SN (2007) TLR4-initiated and cAMP-mediated abrogation of bacterial invasion of the bladder. Cell Host Microbe 1:287–298. https://doi.org/10.1016/j.chom.2007.05.007
Song J, Duncan MJ, Li G, Chan C, Grady R, Stapleton A, Abraham SN (2007) A novel TLR4-mediated signaling pathway leading to IL-6 responses in human bladder epithelial cells. PLoS Pathog 3:e60. https://doi.org/10.1371/journal.ppat.0030060
Spencer JD, Schwaderer AL, Becknell B, Watson J, Hains DS (2014) The innate immune response during urinary tract infection and pyelonephritis. Pediatr Nephrol 29:1139–1149. https://doi.org/10.1007/s00467-013-2513-9
Ingersoll MA, Kline KA, Nielsen HV, Hultgren SJ (2008) G-CSF induction early in uropathogenic Escherichia coli infection of the urinary tract modulates host immunity. Cell Microbiol 10:2568–2578. https://doi.org/10.1111/j.1462-5822.2008.01230.x
Lacerda Mariano L, Ingersoll MA (2018) Bladder resident macrophages: mucosal sentinels. Cell Immunol. https://doi.org/10.1016/j.cellimm.2018.01.018
Song J, Bishop BL, Li G, Grady R, Stapleton A, Abraham SN (2009) TLR4-mediated expulsion of bacteria from infected bladder epithelial cells. Proc Natl Acad Sci U S A 106:14966–14971. https://doi.org/10.1073/pnas.0900527106
Isaacson B, Hadad T, Glasner A, Gur C, Granot Z, Bachrach G, Mandelboim O (2017) Stromal cell-derived factor 1 mediates immune cell attraction upon urinary tract infection. Cell Rep 20:40–47. https://doi.org/10.1016/j.celrep.2017.06.034
Nienhouse V, Gao X, Dong Q, Nelson DE, Toh E, McKinley K, Schreckenberger P, Shibata N, Fok CS, Mueller ER, Brubaker L, Wolfe AJ, Radek KA (2014) Interplay between bladder microbiota and urinary antimicrobial peptides: mechanisms for human urinary tract infection risk and symptom severity. PLoS One 9:e114185. https://doi.org/10.1371/journal.pone.0114185
Liu XJ, Tan Y, Geng YQ, Wang Z, Ye JH, Yin XY, Fu B (2014) Proximal tubule toll-like receptor 4 expression linked to inflammation and apoptosis following hypoxia/reoxygenation injury. Am J Nephrol 39:337–347. https://doi.org/10.1159/000360549
Chassin C, Goujon JM, Darche S, du Merle L, Bens M, Cluzeaud F, Werts C, Ogier-Denis E, Le Bouguenec C, Buzoni-Gatel D, Vandewalle A (2006) Renal collecting duct epithelial cells react to pyelonephritis-associated Escherichia coli by activating distinct TLR4-dependent and -independent inflammatory pathways. J Immunol 177:4773–4784. https://doi.org/10.4049/jimmunol.177.7.4773
Tittel AP, Heuser C, Ohliger C, Knolle PA, Engel DR, Kurts C (2011) Kidney dendritic cells induce innate immunity against bacterial pyelonephritis. J Am Soc Nephrol 22:1435–1441. https://doi.org/10.1681/ASN.2010101072
Bens M, Vimont S, Ben Mkaddem S, Chassin C, Goujon JM, Balloy V, Chignard M, Werts C, Vandewalle A (2014) Flagellin/TLR5 signalling activates renal collecting duct cells and facilitates invasion and cellular translocation of uropathogenic Escherichia coli. Cell Microbiol 16:1503–1517. https://doi.org/10.1111/cmi.12306
Weisheit CK, Engel DR, Kurts C (2015) Dendritic cells and macrophages: sentinels in the kidney. Clin J Am Soc Nephrol 10:1841–1851. https://doi.org/10.2215/CJN.07100714
Bates JM, Raffi HM, Prasadan K, Mascarenhas R, Laszik Z, Maeda N, Hultgren SJ, Kumar S (2004) Tamm-Horsfall protein knockout mice are more prone to urinary tract infection: rapid communication. Kidney Int 65:791–797. https://doi.org/10.1111/j.1523-1755.2004.00452.x
Saemann MD, Weichhart T, Horl WH, Zlabinger GJ (2005) Tamm-Horsfall protein: a multilayered defence molecule against urinary tract infection. Eur J Clin Investig 35:227–235. https://doi.org/10.1111/j.1365-2362.2005.01483.x
Svensson M, Yadav M, Holmqvist B, Lutay N, Svanborg C, Godaly G (2011) Acute pyelonephritis and renal scarring are caused by dysfunctional innate immunity in mCxcr2 heterozygous mice. Kidney Int 80:1064–1072. https://doi.org/10.1038/ki.2011.257
Dustin ML, Rothlein R, Bhan AK, Dinarello CA, Springer TA (1986) Induction by IL 1 and interferon-gamma: tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1). J Immunol 137:245–254
Woodfin A, Beyrau M, Voisin M-B, Ma B, Whiteford JR, Hordijk PL, Hogg N, Nourshargh S (2016) ICAM-1–expressing neutrophils exhibit enhanced effector functions in murine models of endotoxemia. Blood 127:898–907. https://doi.org/10.1182/blood-2015-08-664995
Hughes BJ, Hollers JC, Crockett-Torabi E, Smith CW (1992) Recruitment of CD11b/CD18 to the neutrophil surface and adherence-dependent cell locomotion. J Clin Invest 90:1687–1696. https://doi.org/10.1172/jci116041
Bowen SE, Watt CL, Murawski IJ, Gupta IR, Abraham SN (2013) Interplay between vesicoureteric reflux and kidney infection in the development of reflux nephropathy in mice. Dis Model Mech 6:934–941. https://doi.org/10.1242/dmm.011650
Hang L, Frendéus B, Godaly G, Svanborg C (2000) Interleukin-8 receptor knockout mice have subepithelial neutrophil entrapment and renal scarring following acute pyelonephritis. J Infect Dis 182:1738–1748. https://doi.org/10.1086/317599
De Groote MA, Ochsner UA, Shiloh MU, Nathan C, McCord JM, Dinauer MC, Libby SJ, Vazquez-Torres A, Xu Y, Fang FC (1997) Periplasmic superoxide dismutase protects Salmonella from products of phagocyte NADPH-oxidase and nitric oxide synthase. Proc Natl Acad Sci U S A 94:13997–14001
Tan TK, Zheng G, Hsu TT, Lee SR, Zhang J, Zhao Y, Tian X, Wang Y, Wang YM, Cao Q, Wang Y, Lee VW, Wang C, Zheng D, Alexander SI, Thompson E, Harris DC (2013) Matrix metalloproteinase-9 of tubular and macrophage origin contributes to the pathogenesis of renal fibrosis via macrophage recruitment through osteopontin cleavage. Lab Investig 93:434–449. https://doi.org/10.1038/labinvest.2013.3
Lee S, Huen S, Nishio H, Nishio S, Lee HK, Choi B-S, Ruhrberg C, Cantley LG (2011) Distinct macrophage phenotypes contribute to kidney injury and repair. J Am Soc Nephrol 22:317–326. https://doi.org/10.1681/asn.2009060615
Jin Y, Liu R, Xie J, Xiong H, He JC, Chen N (2013) Interleukin-10 deficiency aggravates kidney inflammation and fibrosis in the unilateral ureteral obstruction mouse model. Lab Investig 93:801. https://doi.org/10.1038/labinvest.2013.64
Rodell CB, Rai R, Faubel S, Burdick JA, Soranno DE (2015) Local immunotherapy via delivery of interleukin-10 and transforming growth factor β antagonist for treatment of chronic kidney disease. J Control Release 206:131–139. https://doi.org/10.1016/j.jconrel.2015.03.025
Nielubowicz GR, Mobley HLT (2010) Host–pathogen interactions in urinary tract infection. Nat Rev Urol 7:430. https://doi.org/10.1038/nrurol.2010.101
Paragas N, Kulkarni R, Werth M, Schmidt-Ott KM, Forster C, Deng R, Zhang Q, Singer E, Klose AD, Shen TH, Francis KP, Ray S, Vijayakumar S, Seward S, Bovino ME, Xu K, Takabe Y, Amaral FE, Mohan S, Wax R, Corbin K, Sanna-Cherchi S, Mori K, Johnson L, Nickolas T, D'Agati V, Lin C-S, Qiu A, Al-Awqati Q, Ratner AJ, Barasch J (2014) α-Intercalated cells defend the urinary system from bacterial infection. J Clin Invest 124:2963–2976. https://doi.org/10.1172/JCI71630
Goetz DH, Holmes MA, Borregaard N, Bluhm ME, Raymond KN, Strong RK (2002) The neutrophil lipocalin NGAL is a bacteriostatic agent that interferes with siderophore-mediated iron acquisition. Mol Cell 10:1033–1043
Owusu-Boaitey N, Bauckman KA, Zhang T, Mysorekar IU (2016) Macrophagic control of the response to uropathogenic E. coli infection by regulation of iron retention in an IL-6-dependent manner. Immun Inflamm Dis 4:413–426. https://doi.org/10.1002/iid3.123
Thumbikat P, Waltenbaugh C, Schaeffer AJ, Klumpp DJ (2006) Antigen-specific responses accelerate bacterial clearance in the bladder. J Immunol 176:3080–3086
Mora-Bau G, Platt AM, van Rooijen N, Randolph GJ, Albert ML, Ingersoll MA (2015) Macrophages subvert adaptive immunity to urinary tract infection. PLoS Pathog 11:e1005044. https://doi.org/10.1371/journal.ppat.1005044
Chan CY, St John AL, Abraham SN (2013) Mast cell interleukin-10 drives localized tolerance in chronic bladder infection. Immunity 38:349–359. https://doi.org/10.1016/j.immuni.2012.10.019
Huttner A, Hatz C, van den Dobbelsteen G, Abbanat D, Hornacek A, Frolich R, Dreyer AM, Martin P, Davies T, Fae K, van den Nieuwenhof I, Thoelen S, de Valliere S, Kuhn A, Bernasconi E, Viereck V, Kavvadias T, Kling K, Ryu G, Hulder T, Groger S, Scheiner D, Alaimo C, Harbarth S, Poolman J, Fonck VG (2017) Safety, immunogenicity, and preliminary clinical efficacy of a vaccine against extraintestinal pathogenic Escherichia coli in women with a history of recurrent urinary tract infection: a randomised, single-blind, placebo-controlled phase 1b trial. Lancet Infect Dis 17:528–537. https://doi.org/10.1016/S1473-3099(17)30108-1
Nagler EV, Williams G, Hodson EM, Craig JC (2011) Interventions for primary vesicoureteric reflux. Cochrane Database Syst Rev 6:CD001532. https://doi.org/10.1002/14651858.CD001532.pub4
Bahat Özdoğan E, Özdemir T, Arslansoyu Çamlar S, İmamoğlu M, Çobanoğlu Ü, Sönmez B, Tosun İ, Doğan İ (2014) Could pyelonephritic scarring be prevented by anti-inflammatory treatment? An experimental model of acute pyelonephritis. Biomed Res Int 2014:134940. https://doi.org/10.1155/2014/134940
Huang Y-Y, Chen M-J, Chiu N-T, Chou H-H, Lin K-Y, Chiou Y-Y (2011) Adjunctive oral methylprednisolone in pediatric acute pyelonephritis alleviates renal scarring. Pediatrics 128:e496–e504. https://doi.org/10.1542/peds.2010-0297
Brown KH, Gaffar A, Alamgir SM (1979) Xerophthalmia, protein-calorie malnutrition, and infections in children. J Pediatr 95:651–656
Kavukcu S, Soylu A, Turkmen M, Sarioglu S, Buyukgebiz B, Gure A (1999) The role of vitamin a in preventing renal scarring secondary to pyelonephritis. BJU Int 83:1055–1059
Zhang G-Q, Chen J-L, Zhao Y (2016) The effect of vitamin a on renal damage following acute pyelonephritis in children: a meta-analysis of randomized controlled trials. Pediatr Nephrol 31:373–379. https://doi.org/10.1007/s00467-015-3098-2
Huang A, Palmer LS, Hom D, Anderson AE, Kushner L, Franco I (1999) Ibuprofen combined with antibiotics suppresses renal scarring due to ascending pyelonephritis in rats. J Urol 162:1396–1398
Matsumoto T, Mizunoe Y, Sakamoto N, Kumazawa J (1990) Suitability of colchicine and superoxide dismutase for the suppression of renal scarring following an infection with bacteria showing mannose-sensitive pili. Nephron 56:130–135. https://doi.org/10.1159/000186120
Delanian S, Baillet F, Huart J, Lefaix JL, Maulard C, Housset M (1994) Successful treatment of radiation-induced fibrosis using liposomal Cu/Zn superoxide dismutase: clinical trial. Radiother Oncol 32:12–20
Zhang H, Sun C, Glogauer M, Bokoch GM (2009) Human neutrophils coordinate chemotaxis by differential activation of Rac1 and Rac2. J Immunol. https://doi.org/10.4049/jimmunol.0900849
Joshi S, Singh AR, Wong SS, Zulcic M, Jiang M, Pardo A, Selman M, Hagood JS, Durden DL (2017) Rac2 is required for alternative macrophage activation and bleomycin induced pulmonary fibrosis; a macrophage autonomous phenotype. PLoS One 12:e0182851. https://doi.org/10.1371/journal.pone.0182851
Amar S, Fields GB (2015) Potential clinical implications of recent MMP inhibitor design strategies. Expert Rev Proteomics 12:445–447. https://doi.org/10.1586/14789450.2015.1069190
Gossage DL, Cieslarova B, Ap S, Zheng H, Xin Y, Lal P, Chen G, Smith V, Sundy JS (2018) Phase 1b study of the safety, pharmacokinetics, and disease-related outcomes of the matrix Metalloproteinase-9 inhibitor Andecaliximab in patients with rheumatoid arthritis. Clin Ther 40:156–165.e155. https://doi.org/10.1016/j.clinthera.2017.11.011
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Murugapoopathy, V., McCusker, C. & Gupta, I.R. The pathogenesis and management of renal scarring in children with vesicoureteric reflux and pyelonephritis. Pediatr Nephrol 35, 349–357 (2020). https://doi.org/10.1007/s00467-018-4187-9
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00467-018-4187-9